Showing results (31-40 of 419) with videos related to

Sort By:
Pageof 42
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2013
PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodiesShuanglong Liu, Dan Li, Ryan Park, et al.
Theranostics|July 12, 2013
Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapyDan Li, Shuanglong Liu, Hong Shan, et al.
Bioconjugate Chemistry|February 14, 2015
Improved metabolic stability for 18F PET probes rapidly constructed via tetrazine trans-cyclooctene ligationRamajeyam Selvaraj, Benjamin Giglio, Shuanglong Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 9, 2013
Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted isletsZhanhong Wu, Shuanglong Liu, Matthew Hassink, et al.
Bioconjugate Chemistry|January 20, 2011
Biological stability evaluation of the α2β1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptideChiun-Wei Huang, Zibo Li, Hancheng Cai, et al.
Molecular Imaging|April 14, 2011
Novel α(2)β(1) integrin-targeted peptide probes for prostate cancer imagingChiun-Wei Huang, Zibo Li, Hancheng Cai, et al.
Current Radiopharmaceuticals|December 24, 2011
(64)Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin αvβ3 expressionHancheng Cai, Zibo Li, Chiun-Wei Huang, et al.
ACS Nano|February 4, 2014
A hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibodySuhaas Rayudu Aluri, Pu Shi, Joshua A Gustafson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2011
Design, synthesis and validation of integrin α2β1-targeted probe for microPET imaging of prostate cancerChiun-Wei Huang, Zibo Li, Hancheng Cai, et al.
Pageof 42